{"id":"aluminium-acetoacetate","rwe":[{"pmid":"33709691","year":"2021","title":"Enzyme-Responsive Biopolymeric Nanogel Fibers by Extrusion: Engineering of High-Surface-Area Hydrogels and Application in Bacterial Enzyme Detection.","finding":"","journal":"ACS applied materials & interfaces","studyType":"Clinical Study"},{"pmid":"25560817","year":"2015","title":"Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy.","finding":"","journal":"The journal of nutrition, health & aging","studyType":"Clinical Study"},{"pmid":"22802208","year":"2012","title":"Direct nanoimprint lithography of Al₂O₃ using a chelated monomer-based precursor.","finding":"","journal":"Nanotechnology","studyType":"Clinical Study"},{"pmid":"18418893","year":"2008","title":"Aluminum-mediated metabolic changes in rat serum and urine: a proton nuclear magnetic resonance study.","finding":"","journal":"Journal of biochemical and molecular toxicology","studyType":"Clinical Study"}],"tags":[{"label":"aluminium acetoacetate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A02AB05","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:31:10.369121","allNames":["aluminium acetoacetate"],"offLabel":[],"synonyms":["aluminium acetoacetate"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"aluminium acetoacetate","explanation":"Imagine aluminium acetoacetate as a 'sponge' that absorbs excess aluminium ions in the body, helping to prevent them from causing harm. This can be especially important for people who have been exposed to high levels of aluminium, such as through certain medical treatments. By binding to aluminium ions, aluminium acetoacetate can help to reduce the risk of aluminium toxicity and its associated health problems.","oneSentence":"Aluminium acetoacetate works by binding to aluminium ions in the body, which can help to reduce aluminium toxicity.","technicalDetail":"Aluminium acetoacetate is a chelating agent that forms a stable complex with aluminium ions, thereby reducing their bioavailability and preventing them from causing oxidative stress and cellular damage."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Aluminium_acetoacetate","title":"Aluminium acetoacetate","extract":"Aluminium acetoacetate is an antacid with the chemical formula C18H27AlO9."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4761","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=aluminium%20acetoacetate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=aluminium acetoacetate","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Aluminium_acetoacetate","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T08:39:21.779212","biosimilars":[],"competitors":[{"drugName":"algeldrate","drugSlug":"algeldrate","fdaApproval":"1983-12-09","relationship":"same-class"},{"drugName":"aluminium phosphate","drugSlug":"aluminium-phosphate","fdaApproval":"","relationship":"same-class"}],"genericName":"aluminium acetoacetate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"_fixedFields":["pubmed(4)"],"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"algeldrate","brandName":"algeldrate","genericName":"algeldrate","approvalYear":"1983","relationship":"same-class"},{"drugId":"aluminium-phosphate","brandName":"aluminium phosphate","genericName":"aluminium phosphate","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06413355","phase":"PHASE1","title":"FAPI-74 PET/CT in Adults With Fibrosis","status":"RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2024-07-16","conditions":["Fibrosis (Morphologic Abnormality)"],"enrollment":45,"completionDate":"2027-07-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UMLSCUI":"C3652633","ChEMBL_ID":"CHEMBL3707335","DRUGBANK_ID":"DB13280","PUBCHEM_CID":"21584777"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":4,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A02AB05","allCodes":["A02AB05"]},"biosimilarFilings":[],"recentPublications":[{"date":"2021 Mar 24","pmid":"33709691","title":"Enzyme-Responsive Biopolymeric Nanogel Fibers by Extrusion: Engineering of High-Surface-Area Hydrogels and Application in Bacterial Enzyme Detection.","journal":"ACS applied materials & interfaces"},{"date":"2015 Jan","pmid":"25560817","title":"Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy.","journal":"The journal of nutrition, health & aging"},{"date":"2012 Aug 10","pmid":"22802208","title":"Direct nanoimprint lithography of Al₂O₃ using a chelated monomer-based precursor.","journal":"Nanotechnology"},{"date":"2008 Mar-Apr","pmid":"18418893","title":"Aluminum-mediated metabolic changes in rat serum and urine: a proton nuclear magnetic resonance study.","journal":"Journal of biochemical and molecular toxicology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"aluminium acetoacetate","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Aluminium acetoacetate is a small molecule drug in the aluminium acetoacetate class, but its target and approved indications are unknown. Its commercial status, including whether it is patented or generic, and whether it is off-patent, is also unclear. As a pharmaceutical professional, further research is necessary to understand its mechanism of action, safety considerations, and pharmacokinetic properties. The original developer and current owner of aluminium acetoacetate are also unknown. More information is needed to provide a comprehensive summary.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}